Survodutide
A Study to Test Different Doses of BI 456906 in Patients With Obesity
Boehringer Ingelheim · Phase 1 · Completed · Enrollment 131
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| BI 456906 | n/r | n/r | n/r | n/r |
| Placebo | n/r | n/r | n/r | n/r |
Not shown
- BI 456906: endpoint not reported
- Placebo: endpoint not reported